skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Meng, Haitao remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Improved long‐term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide‐based front‐line therapy
Improved long‐term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide‐based front‐line therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improved long‐term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide‐based front‐line therapy

Lou, Yinjun ; Lu, Ying ; Zhu, Zhijuan ; Ma, Yafang ; Suo, Shanshan ; Wang, Yungui ; Chen, Dong ; Tong, Hongyan ; Qian, Wenbin ; Meng, Haitao ; Mai, Wenyuan ; Yu, Wenjun ; Xu, Weilai ; Wang, Lei ; Mao, Liping ; Pei, Renzhi ; Jin, Jie

Hematological oncology, 2018-08, Vol.36 (3), p.584-590 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia
Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia

Lou, Yinjun ; Ma, Yafang ; Sun, Jianai ; Suo, Sansan ; Tong, Hongyan ; Qian, Wenbin ; Mai, Wenyuan ; Meng, Haitao ; Jin, Jie

Annals of hematology, 2017-11, Vol.96 (11), p.1793-1800 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
3
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients

Lou, Yinjun ; Ma, Yafang ; Sun, Jianai ; Ye, Xiujin ; Pan, Hanzhang ; Wang, Yungui ; Qian, Wenbin ; Meng, Haitao ; Mai, Wenyuan ; He, JingSong ; Tong, Hongyan ; Jin, Jie

Annals of hematology, 2015-11, Vol.94 (11), p.1829-1837 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
4
Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy
Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy

Lou, Yinjun ; Ma, Yafang ; Suo, Shanshan ; Ni, Wanmao ; Wang, Yungui ; Pan, Hanzhang ; Tong, Hongyan ; Qian, Wenbin ; Meng, Haitao ; Mai, Wenyuan ; Huang, Jian ; Yu, Wenjuan ; Wei, Juyin ; Mao, Liping ; Jin, Jie

Leukemia research, 2015-09, Vol.39 (9), p.938-944 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia: Arsenic trioxide in post-remission therapy
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia: Arsenic trioxide in post-remission therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia: Arsenic trioxide in post-remission therapy

Lou, Yinjun ; Qian, Wenbin ; Meng, Haitao ; Mai, Wenyuan ; Tong, Hongyan ; Tong, Yin ; Huang, Jian ; Jin, Jie

Hematological oncology, 2014-03, Vol.32 (1), p.40-46 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia

Lou, Yinjun ; Qian, Wenbin ; Meng, Haitao ; Mai, Wenyuan ; Tong, Hongyan ; Tong, Yin ; Huang, Jian ; Jin, Jie

Hematological oncology, 2014-03, Vol.32 (1), p.40-46 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia
High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia

Lou, Yinjun ; Qian, Wenbin ; Meng, Haitao ; Mai, Wenyuan ; Tong, Hongyan ; Tong, Yin ; Huang, Jian ; Jin, Jie

Leukemia research, 2013-01, Vol.37 (1), p.37-42 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy
Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy

Lou, Yinjun ; Suo, Shanshan ; Tong, Hongyan ; Ye, Xingnong ; Wang, Yungui ; Chen, Zhimei ; Qian, Wenbin ; Meng, Haitao ; Mai, Wenyuan ; Huang, Jian ; Tong, Yin ; Jin, Jie

Leukemia research, 2013-11, Vol.37 (11), p.1451-1456 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy

Lou, Yinjun ; Suo, Shanshan ; Tong, Yin ; Tong, Hongyan ; Qian, Wenbin ; Meng, Haitao ; Mai, Wenyuan ; Huang, Jian ; Yu, Wenjuan ; Jin, Jie

Annals of hematology, 2014-06, Vol.93 (6), p.941-948 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
10
The clinical efficacy of all-trans retinoic acid plus arsenic trioxide in 177 newly diagnosed acute promyelocytic leukemia patients
The clinical efficacy of all-trans retinoic acid plus arsenic trioxide in 177 newly diagnosed acute promyelocytic leukemia patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

The clinical efficacy of all-trans retinoic acid plus arsenic trioxide in 177 newly diagnosed acute promyelocytic leukemia patients

Lu, Ying ; Li, Fenglin ; Mu, Qitian ; Meng, Haitao ; Qian, Wenbin ; Tong, Hongyan ; Mai, Wenyuan ; Pei, Renzhi ; Yu, Mengxia ; Zhao, Xiaoying ; Jin, Jie

Zhōnghuá xuèyèxué zázhì, 2015-05, Vol.36 (5), p.372-377

China

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (11)

Data de Publicação 

De até
Refinar
  1. Antes de2007  (1)
  2. 2007Até2008  (1)
  3. 2009Até2012  (1)
  4. 2013Até2014  (6)
  5. Após 2014  (5)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (12)
  2. Japonês  (2)
  3. Chinês  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.